¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"xanthine nucleotide"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • xanthine
    Å©»êƾ
  • diphosphopyridine nucleotide
    ÀÌÀλêÇǸ®µò´ºÅ¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
  • single nucleotide polymorphism
    ´ÜÀÏ´ºÅ¬·¹¿ÀƼµå´ÙÇüÅÂ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
  • xanthine
    Å©»êƾ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • xanthine
    Å©»êƾ
  • complementary nucleotide
    »óº¸´ºÅ¬·¹¿ÀƼµå
  • diphosphopyridine nucleotide
    ÀÌÀλêÇǸ®µò´ºÅ¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diphosphopyridine nucleotide =DPN
    ÀÌÀλêÇǸ®µò ´©Å¬·¹¿ÀƼµå.
  • nicotinamide adenine nucleotide
    ´ÏÄÚÆ¾¾Æ¹Ìµå¾Æµ¥´Ñ´©Å¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀŸÀ̵å
  • nucleotide
    ´©Å¬¸®¿ÀŸÀÌ.
  • triphosphopyridine nucleotide
    »ïÀλêÇǸ®µò´©Å¬·¹¿ÀƼµå.
  • xanthine
    »êƾ
  • xanthine bases
    À鯾¿°±â.
  • xanthine calculus
    »êƾ°á¼®, Ȳ»ö¼®.
  • xanthine calculus
    »êƾ°á¼®, Ȳ»ö¼®
  • xanthine derivative
    »êƾÀ¯µµÃ¼.
  • xanthine derivative
    À鯾À¯µµÃ¼.
  • xanthine oxidase
    »êƾ»êÈ­È¿¼Ò
  • xanthine oxidase
    À鯾»êÈ­È¿¼Ò.
  • xanthine stone
    À鯾¼®.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • xanthine
    À鯾
  • xanthine oxidase
    À鯾 ¿Á½Ãµ¥À̽º
  • adenine nucleotide barrier
    ¾Æµ¥´Ñ´©Å¬·¹¿ÀŸÀ̵å À庮(î¡Ûú)
  • block nucleotide
    ºí·Ï ´©Å¬·¹¿ÀŸÀ̵å
  • diphosphopyridine nucleotide
    "ÀÌÀλê(ì£×òß«)ÇǸ®µò ´©Å¬·¹¿ÀŸÀ̵å, (ÔÒ) nicotinamide adenine dinucleotide"
  • fraudulent nucleotide
    À§(êÊ) ´©Å¬·¹¿ÀŸÀ̵å
  • guanine-nucleotide-binding protein
    ±¸¾Æ´Ñ´©Å¬·¹¿ÀŸÀÌµå °áÇÕ ´Ü¹éÁú(Ì¿ùêÓ±ÛÜòõ)
  • nucleotide
    ´©Å¬¸®¿ÀŸÀ̵å
  • nucleotide anhydride
    ¹«¼ö(Ùíâ©) ´©Å¬¸®¿ÀŸÀ̵å
  • nucleotide-binding domain
    ´©Å¬¸®¿ÀŸÀÌµå °áÇÕ¿µ¿ª(Ì¿ùêÖÅæ´)
  • nucleotide coenzyme
    ´©Å¬¸®¿ÀŸÀÌµå º¸È¿¼Ò(ÜÍý£áÈ)
  • nucleotide exchange reaction
    ´©Å¬¸®¿ÀŸÀÌµå ±³È¯¹ÝÀÀ(ÎßüµÚãëë)
  • nucleotide map
    ´©Å¬¸®¿ÀŸÀ̵å Áöµµ(ò¢Óñ)
  • nucleotide pair
    ´©Å¬¸®¿ÀŸÀÌµå ½Ö(äª)
  • nucleotide sugar
    ´©Å¬¸®¿ÀŸÀÌµå ´ç(ÓØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Xan xanthine
XDH xanthine dehydrogenase
XDP xanthine diphosphate; xeroderma pigmentosum
XMP xanthine monophosphate
XO presence of only one sex chromosome; xanthine oxidase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
X-XO Xanthine-xanthine oxidase
MIX 1-Methyl-3-isobutyl-xanthine
1-MX 1-methyl xanthine
1X 1-methyl xanthine
[(3)H]-DPCPX 3)H]-1, 3-dipropyl-,8-cyclopentyl xanthine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nucleotide adenosine triphosphate
    ´ºÅ¬·¹¿ÀƼµå ¾Æµ¥³ë½Å Æ®¸®Æ÷½ºÆäÀÌÆ®
  • xanthine
    ÀÜÆ¾, Å©»êƾ
    1. Ç÷¾×, ¿ÀÁÜ, °£Àå µî¿¡ ÇÔÀ¯µÇ¾î ÀÖ´Â »êÈ­ Ç»¸°. 2. ¹é»öÀÇ ¹«Á¤Çü ¿°±â 2,6-dioxy
  • xanthine base
    »êƾ¿°±â, À鯾¿°±â
  • xanthine derivative
    »êƾÀ¯µµÃ¼, À鯾À¯µµÃ¼
  • xanthine stone
    À鯾¼®
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
xanthine nucleotide The monophosphoric ester of xanthosine. An intermediate in GMP biosynthesis.
Synonym: xanthidylic acid, xanthine nucleotide, xanthylic acid.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
methyl xanthine <chemical, drug> Naturally occurring purine alkaloids such as theobromine, theophylline and caffeine (trimethyl xanthine). They inhibit cAMP phosphodiesterase and thus cause an increase in the intracellular cAMP concentration.
(18 Nov 1997)
xanthine <biochemistry> A purine, the starting point for purine degradation. Its methylated derivatives (theophylline, theobromine, caffeine) are potent cAMP phosphodiesterase inhibitors.
(18 Nov 1997)
xanthine alkaloids Alkaloids, which contain xanthine as their nitrogenous base.
(12 Dec 1998)
xanthine bronchodilator <pharmacology> A group of medications that work by a common mechanism to effect bronchodilation (open up air passages) in the lungs. Used in the treatment of asthma and related conditions.
Examples include: theophylline, aminophylline and dyphylline.
(27 Sep 1997)
xanthine dehydrogenase <enzyme> An enzyme that catalyses the oxidation of xanthine in the presence of NAD+ to form urate and NADH. It acts also on a variety of other purines and aldehydes.
Chemical name: Xanthine:NAD+ oxidoreductase
Registry number: EC 1.1.1.204
(12 Dec 1998)
xanthine oxidase <enzyme> Dehydrogenases involved in conversion of hypoxanthine to xanthine and xanthine to uric acid, as the final catabolism of purines. Deficient in the human disease xanthinuria.
(18 Nov 1997)
xanthine ribonucleoside 9-beta-d-ribosylxanthine;the deamination product of guanosine (O replacing -NH2).
Synonym: xanthine ribonucleoside.
Abbreviation: Xao
(05 Mar 2000)
hypoxanthine-guanine-xanthine phosphoribosyltransferase <enzyme> From tritrichomonas foetus; in contrast to EC 2.4.2.8, this enzyme also uses xanthine as substrate; mw 24 kD
Registry number: EC 2.4.2.-
Synonym: hgxprtase
(26 Jun 1999)
desulfo xanthine dehydrogenase <enzyme> Naturally occuring inactive form of xanthine dehydrogenase
Registry number: EC 1.1.1.-
(26 Jun 1999)
adenine nucleotide A condensation product of adenosine and phosphoric acid; a nucleotide found among the hydrolysis products of all nucleic acids. 3'-Adenylic acid (adenosine 3'-monophosphate) and 5'-adenylic acid (adenosine 5'-monophosphate) differ in the place of attachment of the phosphoric acid to the d-ribose; deoxyadenylic acid differs in having H instead of OH at the 2' position of d-ribose.
See: AMP.
Synonym: adenine nucleotide.
(05 Mar 2000)
adenine nucleotide translocase <enzyme> Catalyses the exchange between endogenous and exogenous adenine nucleotides in mitochondria.ec 2.7.7.-.
Registry number: EC 2.7.7.-
(12 Dec 1998)
cyclic nucleotide A nucleoside monophosphate in which the phosphoryl group is linked twice to the sugar moiety; e.g., adenosine 3',5'-cyclic monophosphate (cAMP).
(05 Mar 2000)
cyclic nucleotide-regulated protein kinases <enzyme> A group of enzymes that catalyses the phosphorylation of serine or threonine residues of proteins and is dependent on cyclic nucleotides.
Registry number: EC 2.7.10.-
(12 Dec 1998)
pyrimidine-5'-nucleotide nucleosidase <enzyme> Also acts on some deoxyribonucleotides
Registry number: EC 3.2.2.10
Synonym: pyr-5'-nt-nucleosidase
(26 Jun 1999)
nicotinamide-nucleotide adenylyltransferase <enzyme> An enzyme that catalyses reversibly the transfer of the adenylyl moiety of ATP to the phosphoryl group of nmn to form NAD+ and pyrophosphate. The enzyme is found predominantly in the nuclei and catalyses the final reaction in the major pathway for the biosynthesis of NAD in mammals.
Chemical name: ATP:nicotinamide-nucleotide adenylyltransferase
Registry number: EC 2.7.7.1
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • xanthine
    Å©»êƾ (Ç÷¾×,¿ÀÁÜ,°£Àå µî¿¡ ÇÔÀ¯µÇ¾î ÀÖ´Â »êÈ­ Ǫ¸°(purine))
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå(ÇÙ»êÀÇ ±¸¼º¼ººÐ)
  • nucleotide sequence
    (»ýÈ­)´ºÅ¬·¹¿ÀƼµå ¹è¿­
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á